This is a registry study that aims to collect patients' data with advanced-stage rare cancer in Asia-Pacific region. Data includes clinical information, details of treatment, prognosis, pathological diagnosis and genetic biomarkers by next-generation sequencing. The relationship between cancer types and prognosis, the effect of treatments, and the cancer type-specific incidence of genomic alterations will be investigated to discover more specific and effective treatment.
Study Type
OBSERVATIONAL
Enrollment
1,000
Genomic sequence
National Cancer Center Hospital, Japan
Chuo-ku, Tokyo, Japan
RECRUITINGHospital Sultan Ismail
Johor Bahru, Johor, Malaysia
RECRUITINGHospital Pulau Pinang
Pulau Pinang, Pulau Pinang, Malaysia
RECRUITINGSarawak General Hospital
Kuching, Sarawak, Malaysia
RECRUITINGHospital Kuala Lumpur
Kuala Lumpur, Malaysia
RECRUITINGUniversity Malaya Medical Center
Kuala Lumpur, Malaysia
RECRUITINGInstitut Kanser negara
Putrajaya, Malaysia
RECRUITINGSt. Luke's Medical Center
Manila, Philippines
RECRUITINGNational Cancer Center Korea
Seoul, South Korea
RECRUITINGNational Taiwan University Hospital
Taipei, Zhongzheng, Taiwan
RECRUITING...and 8 more locations
Overall incidence of any genomic alteration in overall population
Overall incidence of any genomic alteration in overall population
Time frame: 1 year
Overall incidence of any genomic alteration in patients with a certain cancer type
Overall incidence of any genomic alteration in patients with a certain cancer type
Time frame: 1 year
Incidence of individual genomic alteration in overall population
The incidence of individual genomic alterations in overall population
Time frame: 1 year
Incidence of individual genomic alteration in patients with a certain cancer type
The incidence of individual genomic alterations in patients with a certain cancer type
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.